Genetic background is associated with distinct patterns of proarrhythmogenic remodeling leading to atrial fibrillation in pigs with ischemic heart failure - Summary - MDSpire
Advertisement
Genetic background is associated with distinct patterns of proarrhythmogenic remodeling leading to atrial fibrillation in pigs with ischemic heart failure
To investigate the impact of genetic background on ischemia-induced atrial remodeling and the resulting electrophysiological phenotype in a porcine model of ischemic heart failure and atrial fibrillation, highlighting its significance in the context of existing literature.
Key Findings:
Genetic background significantly influences atrial remodeling patterns in response to ischemic heart failure, with implications for clinical practice.
Variability in AF susceptibility among pigs suggests a genetic predisposition modulating arrhythmogenic substrates, warranting further investigation.
Previous studies indicated that genetic factors affect cardiac responses to ischemia/reperfusion, reinforcing the need for personalized approaches.
Interpretation:
The findings highlight the importance of genetic factors in determining individual susceptibility to atrial fibrillation, suggesting that personalized treatment strategies may be necessary to improve patient outcomes.
Limitations:
Study limited to a specific porcine model, which may not fully represent human AF pathology, potentially affecting the applicability of results.
Focus on genetically homogeneous models may overlook the complexity of human genetic diversity, necessitating broader studies.
Conclusion:
Understanding genetic influences on atrial remodeling could lead to improved therapeutic approaches for atrial fibrillation, emphasizing the need for further mechanistic studies that consider genetic diversity.
by Zhihao Zhang, Julia Vlcek, Christina Heger, Valerie Pauly, Nora Hesse, Dominik Schüttler, Daphne Merkus, Eckhard Wolf, Ivica Medugorac, Stefan Kääb, Philipp Tomsits, Sebastian Clauss
Despite major advances in guideline-directed medical therapy (GDMT), worsening heart failure continues to drive significant morbidity, repeat hospitalizations and healthcare utilization worldwide.
In a target-trial emulation of more than 600,000 veterans, GLP-1 RA initiators saw fewer new substance use disorders—and patients with existing SUDs had fewer overdoses, hospitalizations, and deaths.
